
100 years after the discovery of insulin, SCOR is bringing new solutions to the forefront of diabetes management
100 years after the discovery of insulin, SCOR is bringing new solutions to the forefront of diabetes management
SCOR a mis au point un calculateur du risque de récidive "Vitae Breast Cancer"
Presentation
SCOR enregistre un résultat net de EUR 339 millions démontrant sa capacité à absorber les chocs et lance un programme de rachat d’actions de EUR 200 millions
SCOR is revaluating the way we consider risk
Most of us will need long-term care at the end of our lives, yet it is one of the largest uninsured risks facing the elderly.
Presentations made during the Webinar
The 8th annual Global Consumer Study by ReMark, a SCOR Group company, sheds light on what consumers worldwide feel about health, AI, data privacy, and more.
The eighth Prize was awarded to Axel Montagne of the University of Edinburgh
A compelling and poignant look at some of the major events of the past year
Familial Hypercholesterolemia is the most common genetic disease worldwide
Pagination